17156 Psoriasis improvement and satisfaction in patients using a clobetasol spray and oral apremilast combination regimen: A pilot study

This study investigated whether an initial 6-week tapering regimen of clobetasol spray could improve PASI 75 and sPGA response at 16 weeks in patients with moderate to severe psoriasis who initiate apremilast.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Source Type: research